{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:39:15Z","timestamp":1793320755529,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T00:00:00Z","timestamp":1530144000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Future MND","award":["217ARF R43969, 3138"],"award-info":[{"award-number":["217ARF R43969, 3138"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12883-018-1091-7","type":"journal-article","created":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T08:35:10Z","timestamp":1530174910000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":87,"title":["TDP-43 as a potential biomarker for amyotrophic lateral sclerosis: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"18","author":[{"given":"Vivek","family":"Majumder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3337-4079","authenticated-orcid":false,"given":"Jenna M.","family":"Gregory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo A.","family":"Barria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suvankar","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,28]]},"reference":[{"issue":"2","key":"1091_CR1","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.ncl.2017.01.008","volume":"35","author":"NT Olney","year":"2017","unstructured":"Olney NT, Spina S, Miller BL. Frontotemporal Dementia. Neurol Clin. 2017;35(2):339\u201374.","journal-title":"Neurol Clin"},{"key":"1091_CR2","volume-title":"Frontotemporal Dementia: Patient.info\/pro","author":"M Harding","year":"2014","unstructured":"Harding M. Frontotemporal Dementia: Patient.info\/pro; 2014 [updated 19\/9\/2014. Available from: \n                    https:\/\/patient.info\/doctor\/frontotemporal-dementia\n                    \n                  ."},{"issue":"Suppl 1","key":"1091_CR3","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/jnc.13640","volume":"138","author":"RM Tsai","year":"2016","unstructured":"Tsai RM, Boxer AL. Therapy and clinical trials in frontotemporal dementia: past, present, and future. J Neurochem. 2016;138(Suppl 1):211\u201321.","journal-title":"J Neurochem"},{"issue":"5","key":"1091_CR4","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.neurol.2017.04.001","volume":"173","author":"P Couratier","year":"2017","unstructured":"Couratier P, Corcia P, Lautrette G, Nicol M, Marin B. ALS and frontotemporal dementia belong to a common disease spectrum. Rev Neurol (Paris). 2017;173(5):273\u20139.","journal-title":"Rev Neurol (Paris)"},{"issue":"5","key":"1091_CR5","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.neurol.2017.03.031","volume":"173","author":"MH Soriani","year":"2017","unstructured":"Soriani MH, Desnuelle C. Care management in amyotrophic lateral sclerosis. Rev Neurol (Paris). 2017;173(5):288\u201399.","journal-title":"Rev Neurol (Paris)"},{"issue":"8","key":"1091_CR6","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/nrneurol.2012.117","volume":"8","author":"R Rademakers","year":"2012","unstructured":"Rademakers R, Neumann M, Mackenzie IR. Advances in understanding the molecular basis of frontotemporal dementia. Nat Rev Neurol. 2012;8(8):423\u201334.","journal-title":"Nat Rev Neurol"},{"issue":"12","key":"1091_CR7","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s11910-016-0707-9","volume":"16","author":"DA Olszewska","year":"2016","unstructured":"Olszewska DA, Lonergan R, Fallon EM, Lynch T. Genetics of frontotemporal dementia. Curr Neurol Neurosci Rep. 2016;16(12):107.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"1091_CR8","doi-asserted-by":"publisher","first-page":"178.e11","DOI":"10.1016\/j.neurobiolaging.2016.12.013","volume":"51","author":"HA Black","year":"2017","unstructured":"Black HA, Leighton DJ, Cleary EM, Rose E, Stephenson L, Colville S, Ross D, Warner J, Porteous M, Gorrie GH, Swingler R, Goldstein D, Harms MB, Connick P, Pal S, Aitman TJ, Chandran S. Genetic epidemiology of motor neuron disease-associated variants in the Scottish population. Neurobiol Aging. 2017;51:178.e11\u201320.","journal-title":"Neurobiol Aging"},{"key":"1091_CR9","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/ana.23969","volume":"74","author":"S Byrne","year":"2013","unstructured":"Byrne S, Heverin M, Elamin M, Bede P, Lynch C, Kenna K, MacLaughlin R, Walsh C, Al Chalabi A, Hardiman O. Aggregation of neurologic and neuropsychiatric disease in amyotrophic lateral sclerosis kindreds: a population-based case\u2013control cohort study of familial and sporadic amyotrophic lateral sclerosis. Ann Neurol. 2013;74:699\u2013708.","journal-title":"Ann Neurol"},{"issue":"1","key":"1091_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1212\/01.wnl.0000438219.39061.da","volume":"82","author":"SB Gibson","year":"2014","unstructured":"Gibson SB, Figueroa KP, Bromberg MB, Pulst SM, Cannon-Albright L. Familial clustering of ALS in a population-based resource. Neurology. 2014;82(1):17\u201322.","journal-title":"Neurology"},{"issue":"6","key":"1091_CR11","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1177\/106002809703100614","volume":"31","author":"ML Wagner","year":"1997","unstructured":"Wagner ML, Landis BE. Riluzole: a new agent for amyotrophic lateral sclerosis. Ann Pharmacother. 1997;31(6):738\u201344.","journal-title":"Ann Pharmacother"},{"issue":"5796","key":"1091_CR12","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314(5796):130\u20133.","journal-title":"Science"},{"issue":"12","key":"1091_CR13","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1093\/brain\/awx254","volume":"140","author":"DC Perry","year":"2017","unstructured":"Perry DC, Brown JA, Possin KL, Datta S, Trujillo A, et al. Clinicopathological correlations in behavioural variant frontotemporal dementia. Brain. 2017;140(12):3329\u201345.","journal-title":"Brain"},{"issue":"5","key":"1091_CR14","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3109\/00207454.2013.848440","volume":"124","author":"M Hosokawa","year":"2014","unstructured":"Hosokawa M, Arai T, Yamashita M, Tsuji H, Nonaka T, Masuda-Suzukake M, et al. Differential diagnosis of amyotrophic lateral sclerosis from Guillain-Barre syndrome by quantitative determination of TDP-43 in cerebrospinal fluid. Int J Neurosci. 2014;124(5):344\u20139.","journal-title":"Int J Neurosci"},{"issue":"2","key":"1091_CR15","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3109\/17482968.2010.541263","volume":"12","author":"Y Noto","year":"2011","unstructured":"Noto Y, Shibuya K, Sato Y, Kanai K, Misawa S, Sawai S, et al. Elevated CSF TDP-43 levels in amyotrophic lateral sclerosis: specificity, sensitivity, and a possible prognostic value. Amyotroph Lateral Scler. 2011;12(2):140\u20133.","journal-title":"Amyotroph Lateral Scler"},{"issue":"1","key":"1091_CR16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00401-008-0456-1","volume":"117","author":"T Kasai","year":"2009","unstructured":"Kasai T, Tokuda T, Ishigami N, Sasayama H, Foulds P, Mitchell DJ, et al. Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Acta Neuropathol. 2009;117(1):55\u201362.","journal-title":"Acta Neuropathol"},{"issue":"5\u20136","key":"1091_CR17","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3109\/21678421.2014.905606","volume":"15","author":"E Feneberg","year":"2014","unstructured":"Feneberg E, Steinacker P, Lehnert S, Schneider A, Walther P, Thal DR, et al. Limited role of free TDP-43 as a diagnostic tool in neurodegenerative diseases. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15(5\u20136):351\u20136.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"11","key":"1091_CR18","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1001\/archneur.65.11.1481","volume":"65","author":"P Steinacker","year":"2008","unstructured":"Steinacker P, Hendrich C, Sperfeld AD, Jesse S, von Arnim CA, Lehnert S, et al. TDP-43 in cerebrospinal fluid of patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Arch Neurol. 2008;65(11):1481\u20137.","journal-title":"Arch Neurol"},{"issue":"2","key":"1091_CR19","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3233\/JAD-160386","volume":"55","author":"HB Kuiperij","year":"2017","unstructured":"Kuiperij HB, Versleijen AA, Beenes M, Verwey NA, Benussi L, Paterlini A, et al. Tau rather than TDP-43 proteins are potential cerebrospinal fluid biomarkers for frontotemporal lobar degeneration subtypes: a pilot study. J Alzheimers Dis. 2017;55(2):585\u201395.","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"1091_CR20","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1136\/jnnp-2013-305972","volume":"85","author":"M Suarez-Calvet","year":"2014","unstructured":"Suarez-Calvet M, Dols-Icardo O, Llado A, Sanchez-Valle R, Hernandez I, Amer G, et al. Plasma phosphorylated TDP-43 levels are elevated in patients with frontotemporal dementia carrying a C9orf72 repeat expansion or a GRN mutation. J Neurol Neurosurg Psychiatry. 2014;85(6):684\u201391.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"1091_CR21","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12868-017-0334-7","volume":"18","author":"SM Williams","year":"2017","unstructured":"Williams SM, Khan G, Harris BT, Ravits J, Sierks MR. TDP-43 protein variants as biomarkers in amyotrophic lateral sclerosis. BMC Neurosci. 2017;18(1):20.","journal-title":"BMC Neurosci"},{"issue":"2","key":"1091_CR22","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00401-008-0389-8","volume":"116","author":"P Foulds","year":"2008","unstructured":"Foulds P, McAuley E, Gibbons L, Davidson Y, Pickering-Brown SM, Neary D, Snowden JS, Allsop D, Mann DM. TDP-43 protein in plasma may index TDP-43 brain pathology in Alzheimer's disease and frontotemporal lobar degeneration. Acta Neuropathol. 2008;116(2):141\u20136.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"1091_CR23","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3233\/JAD-161116","volume":"58","author":"SM Williams","year":"2017","unstructured":"Williams SM, Schulz P, Rosenberry TL, Caselli RJ, Sierks MR. Blood-based oligomeric and other protein variant biomarkers to facilitate pre-symptomatic diagnosis and staging of Alzheimer's disease. J Alzheimers Dis. 2017;58(1):23\u201335.","journal-title":"J Alzheimers Dis"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-018-1091-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12883-018-1091-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-018-1091-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T19:09:35Z","timestamp":1561662575000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-018-1091-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,28]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1091"],"URL":"https:\/\/doi.org\/10.1186\/s12883-018-1091-7","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,28]]},"assertion":[{"value":"27 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"N\/A","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N\/A","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"90"}}